Keyphrases
Blood-brain Barrier
57%
Intracranial Pressure Elevation
53%
Ischemic Stroke
51%
Cerebrospinal Fluid
48%
Increased Intracranial Pressure
42%
Neurological Diseases
40%
Intracranial Pressure
40%
Paxalisib
38%
Blood-brain Barrier Disruption
32%
Cerebrospinal Fluid Secretion
29%
Brain Fluids
27%
NKCC1
24%
Blood-brain Barrier Model
23%
Porcine Blood
23%
Porcine Brain
22%
Ultrashort
19%
Endothelial Cell Isolation
19%
Endothelial Cell Culture
19%
Stroke Outcome
19%
Functional Studies
19%
Healthy Rats
19%
Outflow Resistance
19%
Dynamic Pressure
19%
Cerebrospinal Fluid Dynamics
19%
Phase II Clinical Trial
19%
Cortical Ischemia
19%
Transient Receptor Potential Vanilloid 4 (TRPV4)
19%
Diffuse Midline Glioma
19%
ONC201
19%
H3 K27-altered
19%
Human Brain Microvascular Endothelial Cells (HBMEC)
19%
Screening Study
19%
Permeability Screening
19%
Blood-brain Distribution
19%
Atrial Fibrillation
19%
Hypothermia
19%
Dementia Risk
19%
Antagonism
19%
Potential Contributor
19%
Neuroinfection
19%
In Vitro Blood-brain Barrier Model
16%
Pressure Rise
16%
Fluid Dynamics
16%
Cerebrospinal Fluid Drainage
14%
Porcine Brain Endothelial Cells
14%
Pathophysiology
12%
Astrocytes
11%
Drug Permeation
11%
Cellular Mechanisms
11%
Life-threatening
11%
Neuroscience
Blood Brain Barrier
100%
Hypothermia
77%
Brain Ischemia
73%
In Vitro
37%
Nervous System Disorder
34%
Astrocyte
33%
Central Nervous System
28%
Microvessel
23%
Vanilloid Receptor 4
19%
Nervous System Infectious Disease
19%
Proteolysis
19%
TP53
19%
Pons
19%
Acid Protein
19%
Electron Transport Chain
19%
Endopeptidase Clp
19%
Japanese Encephalitis Virus
19%
Radiation Therapy
19%
Lymph Node
19%
Neuroprotective Agent
13%
Acetazolamide
9%
Neuroprotection
8%
Middle Cerebral Artery
7%
In Vivo
7%
Tight Junction
7%
Neurological Disorder
5%
Medicine and Dentistry
Brain Ischemia
43%
Cerebrospinal Fluid
38%
Intracranial Pressure
38%
Hypothermia
38%
Apoplexy
23%
Experimental Stroke
21%
Blood Brain Barrier
19%
Ganglioglioma
19%
In Vitro
19%
Clinical Trial
19%
Neoplasm
19%
Infarction
12%
Re-Irradiation
9%
Overall Survival
9%